|
Post by observingthechaos on Jun 19, 2015 14:30:57 GMT
Possibility all this downward pressure down here is from caladrius getting bumped off of the russell index.
|
|
|
Post by jckrdu on Jun 19, 2015 14:59:06 GMT
Possibility all this downward pressure down here is from caladrius getting bumped off of the russell index. That's probably it. Do you know the specific Russell index they're current on, and what the market cap requirement is?
If that's what's causing the selling pressure, it should be temporary. I keep adding in small increments with every .05 move lower.
Given that they recently closed some clean financing (no warrants) at $2, I feel pretty confident this will rebound in the not too distant future.
|
|
|
Post by observingthechaos on Jun 19, 2015 15:26:19 GMT
Looks like its the global index www.russell.com/indexes/americas/tools-resources/reconstitution/additions-deletions.page#deletionHere is the methodology www.russell.com/documents/indexes/construction-methodology-global-indexes.pdflooks like the min market cap is 1 mil which we are above. "On the last trading day of May each year, all globally eligible securities are ranked by total market capitalization. All companies whose stocks are listed on eligible stock exchanges in eligible c ountries are considered for inclusion in the Russell Global Index. The largest 98% of securities in the U.S. and in the rest of the world become the Russell Global Index. All sub - indexes are determined from that set of securities. S ee Sections 2 through 5 for more detail." from section 2: "The Russell Global Index is fundamentally constructed from a company - level perspective. Every publicly traded company around the world that meets minimum size and investability standards is included in the stock universe. Russell uses seven steps to refine the exchange - traded securities universe and capture the total institutional universe of securities on which the Russell Global Index is based. Steps in constructing the investable equities universe and the Russell Global Index 1. Evaluate security types and distinguish equity securities from all other securities 2. Assign companies to countries 3. Evaluate secur ities by country to remove ineligible types 4. Evaluate minimum capitalization size requirements 5. Evaluate country eligibility based on economic and practical investment environments 6. Evaluate minimum stock liquidity by using the average daily dollar trading volume (ADDTV), and active trading ratio (ATR) 7. Capture 98% of the institutionally investable universe " So, perhaps that isn't the reason...I'm not sure who has their money tied into 98% of stocks across the globe...I mean if diversification is your strategy...
|
|
|
Post by jckrdu on Jun 19, 2015 20:12:27 GMT
Possibility all this downward pressure down here is from caladrius getting bumped off of the russell index. That's probably it. Do you know the specific Russell index they're current on, and what the market cap requirement is?
If that's what's causing the selling pressure, it should be temporary. I keep adding in small increments with every .05 move lower.
Given that they recently closed some clean financing (no warrants) at $2, I feel pretty confident this will rebound in the not too distant future.
Nice 10% turnaround the last hour of the day on high volume.
Hopefully that marks $1.82 as the bottom.
|
|
|
Post by observingthechaos on Jun 19, 2015 21:42:23 GMT
Love the enthusiasm, seems like a cheap trick by the underwriters that bought at 2 in my opinion. I am very skeptical anymore, especially after Advaxis just went from 30 to 20 right after the 19 dollar buy in. Just stinks like manipulation anymore in these bios. I've been slowly accumulating under 2 so I hope you are right.
|
|
|
Post by jckrdu on Jun 19, 2015 22:37:41 GMT
Love the enthusiasm, seems like a cheap trick by the underwriters that bought at 2 in my opinion. I am very skeptical anymore, especially after Advaxis just went from 30 to 20 right after the 19 dollar buy in. Just stinks like manipulation anymore in these bios. I've been slowly accumulating under 2 so I hope you are right. I think you were right that the move off the Russell indexes is driving some of the selling. If you look at that first link you provided, CLDS is set to move off the Global and 3000 indexes. Most likely some institutions selling ahead of 6/26 to rebalance, IMO.
If that's what's happening, I do believe the selling is temporary, and will be replaced by buying once everyone has rebalanced. Maybe that re-buying started to happen late this afternoon. IMO, the fundamentals won't keep this below $2 for long.
|
|
|
Post by jckrdu on Jun 23, 2015 11:45:28 GMT
|
|
|
Post by observingthechaos on Jun 29, 2015 22:11:35 GMT
I like the fact that we held today even with the geo-political volatility that seems to be affecting a lot of other stocks.
|
|
|
Post by jckrdu on Jul 15, 2015 15:23:48 GMT
Added more today. Starting to accumulate more CLBS in anticipation of Japan partnership news sometime "this summer".
|
|
|
Post by guruzim on Jul 20, 2015 17:12:31 GMT
jckrdu - I've been watching this one for a while. What made you think the downward trend was over, and do you still feel that way today? Not trying to I-told-you so or anything, I think you make sound decisions but I haven't thought we were at a floor yet. I'm quite close to pulling the trigger on this one and could go either way today. The $.07 drop that I saw earlier almost got me in...
|
|
|
Post by jckrdu on Jul 20, 2015 17:36:14 GMT
jckrdu - I've been watching this one for a while. What made you think the downward trend was over, and do you still feel that way today? Not trying to I-told-you so or anything, I think you make sound decisions but I haven't thought we were at a floor yet. I'm quite close to pulling the trigger on this one and could go either way today. The $.07 drop that I saw earlier almost got me in... Yes, I still feel the downward trend is mostly over. Can't rule out a drop a little lower than $1.80, but IMO the low $1.80s is at or near the bottom.
The reason why I hold that belief is that I think (based on CEO comments) that news is coming sometime "this summer" on Japan partnership news for limb ischemia, and maybe partnership news for diabetes. So yeah, pps is still at risk until we get news.
The upcoming earnings call (sometime in the next 2 weeks I think) is both a potential catalyst and a risk. If the CEO paints a bullish picture based on the cell-processing divisions' results, it could start moving higher. If results and the cell processing division outlook is poor (new business, costs, etc) then it could drag the whole company lower.
In the end, I think partnership news takes CLBS higher (well over the offering price of $2) sometime before the end of the summer, so I'll continue to add shares if the pps continues to slide down.
|
|
|
Post by jckrdu on Jul 23, 2015 12:16:27 GMT
jckrdu - I've been watching this one for a while. What made you think the downward trend was over, and do you still feel that way today? Not trying to I-told-you so or anything, I think you make sound decisions but I haven't thought we were at a floor yet. I'm quite close to pulling the trigger on this one and could go either way today. The $.07 drop that I saw earlier almost got me in... Yes, I still feel the downward trend is mostly over. Can't rule out a drop a little lower than $1.80, but IMO the low $1.80s is at or near the bottom.
The reason why I hold that belief is that I think (based on CEO comments) that news is coming sometime "this summer" on Japan partnership news for limb ischemia, and maybe partnership news for diabetes. So yeah, pps is still at risk until we get news.
The upcoming earnings call (sometime in the next 2 weeks I think) is both a potential catalyst and a risk. If the CEO paints a bullish picture based on the cell-processing divisions' results, it could start moving higher. If results and the cell processing division outlook is poor (new business, costs, etc) then it could drag the whole company lower.
In the end, I think partnership news takes CLBS higher (well over the offering price of $2) sometime before the end of the summer, so I'll continue to add shares if the pps continues to slide down.
News of a small grant today in an area not previously discussed as a target by the company. Hopefully this helps set the low $1.80s as the floor.
finance.yahoo.com/news/caladrius-biosciences-announces-nih-grant-113000791.html
|
|
|
Post by jckrdu on Jul 27, 2015 17:16:53 GMT
FYI - I sold a chunk of shares this morning to take advantage of an unexpected opportunity that surfaced elsewhere. I intend to keep acquiring CLBS as I can in anticipation of Japan partnership news sometime this summer.
|
|
|
Post by wanderer on Jul 28, 2015 6:25:34 GMT
That opportunity wouldn't happen to be OCAT would it? I was able to grab a few below 4 as well. I am looking to aquire another small chunk of CLBS before it starts to rise hopefully next month.
|
|
|
Post by Macgruber on Aug 3, 2015 15:48:26 GMT
Anyone buying more here today?This trading below 1.60 has me interested
|
|
|
Post by jckrdu on Aug 3, 2015 16:06:16 GMT
Anyone buying more here today?This trading below 1.60 has me interested I'm going to wait for earnings this Thursday, 8/6 before I consider adding. (I actually sold a small amount of shares this morning to build some cash.)
CLBS is one of the few stem cell companies where earnings and their outlook matters, as they have their cell processing group, PCT. If earnings are good and they issue a positive outlook, this could rebound nicely. If earnings miss and the CEO gives a cautious outlook, it could tank further.
I'll add more if it moves lower on Friday, as I believe the partnership news is coming over the next 1-2 months.
|
|
|
Post by Macgruber on Aug 3, 2015 16:34:56 GMT
Thanks for the input. You building cash for more ONCS? Im torn between the two right now. Might just stay out of this one and add more on the ONCS pullbacks.
|
|
|
Post by jckrdu on Aug 3, 2015 17:01:50 GMT
Thanks for the input. You building cash for more ONCS? Im torn between the two right now. Might just stay out of this one and add more on the ONCS pullbacks. Building more cash for whichever one moved lower (OCAT or ONCS). I just added more OCAT in the $4.20s.
|
|
|
Post by Macgruber on Aug 3, 2015 23:08:13 GMT
Like your style jck, I think Ill stay out of CLBS for now and take a look at those two. Ive been burned by both OCAT and ONCS heavily in the past and would like some retribution. Prepare the indian war drums..... OCATA!!!!
|
|
|
Post by jckrdu on Aug 3, 2015 23:24:27 GMT
Like your style jck, I think Ill stay out of CLBS for now and take a look at those two. Ive been burned by both OCAT and ONCS heavily in the past and would like some retribution. Prepare the indian war drums..... OCATA!!!!
My shorter term plan - I'm still holding CLBS (and ATHX) as I believe both will move higher (from what level is TBD) sometime this summer when both companies announce partnership news. I intend to take some profits on news from the first one that announces a partnership, and move those profits into the other one... and then wait for the 2nd partnership news.
My Longer term plan - Once ATHX and CLBS both announce their partnerships, I'm planning to rotate back into OCAT and ONCS with a larger position, as I believe both will be announcing great Phase 2 data sometime in 2016 that will increase the market caps of both companies considerably. I like both ONCS and OCAT at current levels, but believe some patience with CLBS and ATHX will pay off by the end of September.... and will allow me to buy more ONCS and OCAT.
I'm sure there will be trading opportunities on the way, but that's my general plan fwiw.
|
|